Third Point - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Third Point ownership history of BAXTER INTL INC
ValueSharesWeighting
Q2 2020$344,400,000
-63.4%
4,000,000
-65.5%
4.72%
-68.6%
Q1 2020$940,180,000
-35.8%
11,580,000
-33.8%
15.00%
-10.8%
Q4 2019$1,463,350,000
-0.7%
17,500,000
+3.9%
16.83%
-3.9%
Q3 2019$1,473,870,000
-21.8%
16,850,000
-26.7%
17.51%
-20.6%
Q2 2019$1,883,700,000
-17.3%
23,000,000
-17.9%
22.06%
-12.9%
Q1 2019$2,276,680,000
+23.5%
28,000,0000.0%25.31%
-10.6%
Q4 2018$1,842,960,000
-33.6%
28,000,000
-22.2%
28.32%
+46.0%
Q3 2018$2,775,240,000
+4.4%
36,000,0000.0%19.40%
+4.7%
Q2 2018$2,658,240,000
+13.5%
36,000,0000.0%18.52%
+5.4%
Q1 2018$2,341,440,000
+0.6%
36,000,0000.0%17.58%
+4.7%
Q4 2017$2,327,040,000
-9.6%
36,000,000
-12.2%
16.80%
-22.3%
Q3 2017$2,572,750,000
+3.7%
41,000,0000.0%21.63%
-1.7%
Q2 2017$2,482,140,000
+4.0%
41,000,000
-10.9%
22.00%
-5.5%
Q1 2017$2,385,560,000
+3.7%
46,000,000
-11.4%
23.28%
+3.1%
Q4 2016$2,301,324,000
-6.8%
51,901,7670.0%22.59%
+5.2%
Q3 2016$2,470,524,000
+5.3%
51,901,7670.0%21.48%
-4.0%
Q2 2016$2,346,998,000
+6.1%
51,901,767
-3.6%
22.37%
+9.8%
Q1 2016$2,212,158,000
+7.7%
53,850,0000.0%20.38%
-2.2%
Q4 2015$2,054,378,000
+16.1%
53,850,0000.0%20.84%
+24.9%
Q3 2015$1,768,972,000
+540.4%
53,850,000
+1263.3%
16.69%
+545.1%
Q2 2015$276,224,0003,950,0002.59%
Other shareholders
BAXTER INTL INC shareholders Q3 2023
NameSharesValueWeighting ↓
Third Point 41,000,000$2,482,140,00022.00%
THUNDERBIRD PARTNERS LLP 1,711,643$103,623,00012.17%
SECTOR GAMMA AS 1,070,333$64,798,0009.42%
Veritas Asset Management LLP 10,179,102$616,243,0004.81%
13D Management LLC 194,807$11,794,0004.18%
Progressive Investment Management Corp 78,316$4,741,0003.69%
Aristotle Capital Management, LLC 6,846,307$414,476,0003.46%
ARGENT CAPITAL MANAGEMENT LLC 1,394,075$84,397,0003.37%
Lipe & Dalton 80,073$4,848,0003.14%
PURA VIDA INVESTMENTS, LLC 125,000$7,568,0003.00%
View complete list of BAXTER INTL INC shareholders